12th week of 2013 patent applcation highlights part 50 |
Patent application number | Title | Published |
20130072537 | ENANTIOMERS OF SPIRO-OXINDOLE COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS - This invention is directed to the (S)-enantiomer of the compound of formula (I): | 2013-03-21 |
20130072538 | USE OF TETRAMIC ACID DERIVATIVES FOR INSECT CONTROL - The present invention relates to the use of compounds of the formula (I) | 2013-03-21 |
20130072539 | Anti-Cancer Tamoxifen-Melatonin Hybrid Ligand - A particularly constructed tamoxifen-melatonin hybrid ligand gives new and unexpectedly improved results in the prevention and treatment of cancer, particularly breast cancer. The hybrid ligand comprises either tamoxifen or 4-hydroxy-tamoxifen and also melatonin, with the tamoxifen or 5-hydroxy-tamoxifen and melatonin's being linked by an unsubstituted C | 2013-03-21 |
20130072540 | RNA interference of galectin-3 expression and methods of use thereof - Galectin-3 is a pro-inflammatory molecule functioning as a cytokine hub, and also regulates unfolded protein responses (UPR) and ER stress. Thus, galectin-3 serves as a target for ameliorating inflammatory diseases such as allergic inflammation and diabetic inflammation and insulin resistance. RNA interference of endogenous galectin-3 expression, upregulates IL-12, IL-10 while downregulating IL-23 production, which offers protection against allergic inflammation. In addition, endogenous galectin-3 knockdown causes upregulation of XBP1, alleviating ER stress. Together, upregulated XBP1 and IL-10 offer protection against obesity-induced inflammation. Therefore, the embodiment of the invention resides in RNA interference of endogenous galectin-3 in appropriate cell types in order to rectify allergic and/or diabetic inflammation. | 2013-03-21 |
20130072541 | ADENO-ASSOCIATED VIRAL VECTOR FOR EXON SKIPPING IN A GENE ENCODING A DISPENSIBLE-DOMAIN PROTEIN - The invention concerns an adeno-associated viral vector comprising:
| 2013-03-21 |
20130072542 | PISCINE REOVIRUS DIAGNOSTIC COMPOSITIONS - The invention is directed to a isolated a Piscine reovirus associated with HSMI in teleosts, and isolated nucleic acids sequences and peptides thereof. The invention also relates to diagnostic antibodies against antigens derived from Piscine re-oviruses. In another aspect, the invention relates to iRNAs which target nucleic acid sequences of Piscine reoviruses. In another aspect, the invention is related to methods for detecting the presence or absence of Piscine reoviruses in an animal. | 2013-03-21 |
20130072543 | Compounds and Compositions for Nucleic Acid Formulation and Delivery - The invention relates to compositions containing compounds of formula I: | 2013-03-21 |
20130072544 | DETECTION OF HBX/8P11 HYBRID SEQUENCE IN HUMAN HEPATOCELLULAR CARCINOMA - The present invention provides a method for diagnosing a particular type of human hepatocellular carcinoma (HCC), HBx/8p11-positive HCC, in a subject by detecting the presence of a specific, non-naturally occurring polynucleotide sequence that indicates integration of a portion of the human hepatitis B virus (HBV) sequence into the human genome on chromosome 8 in the 8p11 integration region. A kit and device useful for such a method are also provided. In addition, the present invention provides a method for treating an HBx/8p11-positive HCC. | 2013-03-21 |
20130072545 | MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT - The invention relates to the diagnostic and therapeutic uses of a miRNA molecule or an equivalent thereof wherein a source of said miRNA molecule or equivalent thereof comprises at least 80 nucleotides and comprises a motif having at least 98% identity with the motif represented by SEQ ID NO:1 or a source thereof in a disease and condition associated with EMT (Epithelial to Mesenchymal Transition). | 2013-03-21 |
20130072546 | TREATMENT OF METHIONINE SULFOXIDE REDUCTASE A (MSRA) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO MSRA - The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of Methionine Sulfoxide Reductase A (MSRA), in particular, by targeting natural antisense polynucleotides of Methionine Sulfoxide Reductase A (MSRA). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of MSRA. | 2013-03-21 |
20130072547 | USE OF TOLL-LIKE RECEPTOR-9 AGONISTS, TOLL-LIKE RECEPTOR-4 ANTAGONISTS, AND/OR NUCLEAR OLIGOMERIZATION DOMAIN-2 AGONISTS FOR THE TREATMENT OF PREVENTION OF TOLL-LIKE RECEPTOR-4-ASSOCIATED DISORDERS - The present invention relates to the use of a TLR9 agonist and/or a TLR4 antagonist and/or a NOD2 agonist for treatment or prevention of disorders involving TLR4 activation, such as systemic sepsis and necrotizing enterocolitis. | 2013-03-21 |
20130072548 | Scalable Manufacturing Platform for Viral Vector Purification and Viral Vectors So Purified for Use in Gene Therapy - Methods for preparing highly purified AAV vector formulations are provided. The highly pure AAV formulations described herein are superior for clinical use. | 2013-03-21 |
20130072549 | METHODS OF TREATING CARDIOMYOPATHY - A method of treating a cardiomyopathy in a subject includes administering to the subject a therapeutically effective amount of an agent that modulates contractile function in myocardial tissue of the subject. | 2013-03-21 |
20130072550 | PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPalpha SECRETION AND IMROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS - The present disclosure relates to methods of administering compounds for treating conditions associated with amyloid processing such as Alzheimer's Disease. Methods are disclosed comprising the step of administering a macrocyclic lactone, a benzolactam, a pyrrolidinone or a combination thereof to a subject in need in an amount effective to decrease soluble Aβ-40 or Aβ-42, or to lower total amyloid precursor protein (“APP”). Methods are also disclosed further comprising the step of identifying a subject with increased soluble Aβ-40 or Aβ-42 levels, or elevated APP levels compared to a control population. | 2013-03-21 |
20130072551 | USE OF A BETA BLOCKER FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HEMANGIOMAS - The present technology relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for example of infantile hemangiomas. The beta blocker may be a non-selective beta-blocker, for example propranolol. The present technology provides an alternative to the known compounds, e.g. corticosteroids, interferon or vincristine, generally used for the treatment of hemangiomas. | 2013-03-21 |
20130072552 | CRYSTALLINE HYDROCHLORIDE SALT OF DARUNAVIR - The present invention provides novel crystalline hydrochloride salt of darunavir, process for its preparation and to pharmaceutical composition comprising it. The present invention also provides novel process for preparation of darunavir amorphous form and pharmaceutical composition comprising it. | 2013-03-21 |
20130072553 | DRUGS, DERIVATIVES AND ANALOGS CONTAINING ADAMANTANE STRUCTURES OF NEW INDICATION APPLICATIONS OF ANTI-TUMOR - This invention relates to the drugs, derivatives and analogs containing adamantane structures of new indication applications of anti-tumor. The invention also relates to above compounds to treat tumors and other diseases with FIG. | 2013-03-21 |
20130072554 | Novel Method For Delivery and Use of Isothiocyanates For Prophylaxis and/or Therapy of Bladder Cancer - Provided is a composition that contains a mixture of broccoli seed and mustard seed. Before mixing the broccoli seed with the mustard seed, the broccoli seed is subjected to baking and a pressurized heat treatment. The broccoli seed is baked at a temperature of at least 200 degrees Fahrenheit for at least 60 minutes, and is subjected to a pressurized heat treatment of at least 200 degrees Fahrenheit at a pressure of at least 10 pounds/square inch for at least 5 minutes. Also provided is a method for therapy and/or prophylaxis of bladder cancer in an individual. The method entails administering orally to the individual a composition that contains an isothiocyanate (ITC) or a derivative thereof such that the administration inhibits the growth and/or recurrence of bladder cancer. Nutraceutical compositions are also provided. | 2013-03-21 |
20130072555 | COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES - In one aspect of the present invention, a pharmaceutical composition for treating a metabolic disease in a mammalian subject includes a therapeutically effective amount of (R)-all-trans-13,14-dihydroretinol and a pharmaceutically acceptable carrier or diluent. In another aspect of the present invention, pharmaceutical composition for treating a metabolic disease in a mammalian subject includes a therapeutically effective amount of (S)-all-trans-13,14-dihydroretinol and a pharmaceutically acceptable carrier or diluent. In a further aspect of the present invention, a method is provided for treating a metabolic disease in a mammalian subject. The method includes administering to the subject a pharmaceutical composition comprising at least one all-trans-13,14-dihydroretinoid, all-trans-13,14-dihydroretinoid derivative, or agent capable of modulating the level of at least one all-trans-13,14-dihydroretinoid or all-trans-13,14-dihydroretinoid derivative in the subject. | 2013-03-21 |
20130072556 | RETINAL DERIVATIVES AND METHODS FOR THE USE THEREOF FOR THE TREATMENT OF VISUAL DISORDERS - Compositions of and methods for using synthetic retinal derivatives as retinoid replacements and opsin agonists are provided. | 2013-03-21 |
20130072557 | METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION - A method of treating or preventing age-related retinal dysfunction involves administering to a patient a pharmaceutically effective amount of a synthetic retinal derivative repeatedly over a duration of at least about 3 months. Effective synthetic retinal derivatives include 9-cis-retinyl esters, 11-cis-retinyl esters, derivatives and congeners thereof, and combinations thereof. Suitable ester substituents include carboxylates of C | 2013-03-21 |
20130072558 | METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION - A method of treating or preventing age-related retinal dysfunction involves administering to a patient a pharmaceutically effective amount of a synthetic retinal derivative repeatedly over a duration of at least about 3 months. Effective synthetic retinal derivatives include 9-cis-retinyl esters, 11-cis-retinyl esters, derivatives and congeners thereof, and combinations thereof. Suitable ester substituents include carboxylates of C | 2013-03-21 |
20130072559 | RETINAL DERIVATIVES AND METHODS FOR THE USE THEREOF FOR THE TREATMENT OF VISUAL DISORDERS - Compositions of and methods for using synthetic retinal derivatives as retinoid replacements and opsin agonists are provided. | 2013-03-21 |
20130072560 | RETINAL DERIVATIVES AND METHODS FOR THE USE THEREOF FOR THE TREATMENT OF VISUAL DISORDERS - Compositions of and methods for using synthetic retinal derivatives as retinoid replacements and opsin agonists are provided. | 2013-03-21 |
20130072561 | METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION - A method of treating or preventing age-related retinal dysfunction involves administering to a patient a pharmaceutically effective amount of a synthetic retinal derivative repeatedly over a duration of at least about 3 months. Effective synthetic retinal derivatives include 9-cis-retinyl esters, 11-cis-retinyl esters, derivatives and congeners thereof, and combinations thereof. Suitable ester substituents include carboxyiates of C | 2013-03-21 |
20130072562 | TUMOR NECROSIS FACTOR INHIBITORS - The present invention is directed to compounds that are allosteric inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and compositions thereof in the treatment of TNF-α mediated conditions. | 2013-03-21 |
20130072563 | PERACID AND 2-HYDROXY ORGANIC ACID COMPOSITIONS AND METHODS FOR SANITATION AND DISEASE PREVENTION - Methods and compositions for treating living surfaces to control microorganisms are provided. The method treats produce by contacting a living surface with an aqueous solution comprising i) an organic peracid of the formula RC(O)OOH wherein R is methyl, ethyl, n-propyl, or s-propyl; ii) a 2-hydroxy organic acid selected from tartaric acid, citric acid, malic acid, mandelic acid, and lactic acid; and iii) water. | 2013-03-21 |
20130072564 | PEPTIDE AND SMALL MOLECULE AGONISTS OF EPHA AND THEIR USES - Methods and compositions for activating an EphA receptor can be used for identifying therapeutic agents for cancer. | 2013-03-21 |
20130072565 | METHOD OF INCREASING CELL PROLIFERATION BY ADVANCED WOUND DRESSINGS - The present invention relates generally to a method for stimulating cell proliferation. More specifically this invention discloses the use of increased cell proliferation in treatment of certain wounds. | 2013-03-21 |
20130072566 | ANTIMICROBIAL COMPOSITIONS - Antimicrobial compositions are provided that include a hydroalcoholic solvent system comprising a lower C | 2013-03-21 |
20130072567 | TREATMENT OF FAECAL INCONTINENCE AND OTHER CONDITIONS WITH 1R, 2S-METHOXAMINE - 1R,2S-Methoxamine may be used topically for effective treatment of faecal incontinence at low doses without local or systemic side effects, for example, without affecting blood pressure. 1R,2S-Methoxamine may be used to treat other disturbances and disorders of the gastro-intestinal, as a pressor agent, as a nasal decongestant and in ophthalmology, at low does and without significant side effects. | 2013-03-21 |
20130072568 | RETINOID REPLACEMENTS AND OPSIN AGONISTS AND METHODS FOR THE USE THEREOF - Compositions of and methods for using synthetic retinoids as retinoid replacements and opsin agonists are provided. | 2013-03-21 |
20130072569 | RETINOID REPLACEMENTS AND OPSIN AGONISTS AND METHODS FOR THE USE THEREOF - Compositions of and methods for using synthetic retinoids as retinoid replacements and opsin agonists are provided. | 2013-03-21 |
20130072570 | Interomone Compositions and Their Use to Modify Behavior in Different Vertebrate Species - A composition comprising an interomone is described for the modification of undesirable or harmful stress-related behaviors or other behaviors or physiology in a variety of vertebrate species, as well as methods of using the compositions in vertebrates from a species different than the species in which the interomone is a naturally occurring pheromone. | 2013-03-21 |
20130072571 | EVAPORATIVE COOLING COMPOSITION - A liquid evaporative cooling composition has been discovered which is peculiarly effective in providing relief from heat-related discomfort. The composition utilizes a concentrate, dissolved in water, which preferably consists essentially of (a) about forty-three percent by weight of an alcohol; (b) about twelve percent by weight of a surfactant; (c) about four percent by weight of an aromatic oil; (d) about one percent by weight of a cooling agent; and (e) about forty percent by weight of water. | 2013-03-21 |
20130072572 | New Signaling Molecule Involved in Ultraviolet Damage to Skin - The present invention includes a method of detecting ultraviolet radiation (UVR)-induced skin damage in a mammal. The present invention also includes a method of identifying a mammal at risk of developing U VR-induced skin damage, photoaging, or photocarcinogenesis. The present invention further includes a method of inhibiting UVR-induced skin damage in a mammal at risk of developing U VR-induced skin damage. The present invention also includes a method of reducing the level of Syk kinase in the skin of a mammal. The present invention further includes methods of treating or diagnosing a disease associated with a change of Syk kinase expression in the skin in a mammal. | 2013-03-21 |
20130072573 | PROCESS FOR PREPARING EXTRA PURE 2, 6-DIISOPROPYL PHENOL - Disclosed herein is a process for the preparation of highly pure 2,6-diisopropyl phenol (Formula I), which comprises reacting p-hydroxy benzoic acid (Formula II) with an alkylating agent in presence of aq. mineral acid followed by basilication and subsequent washings to yield 4-hydroxy-3,5-diisopropylbenzoic acid (Formula III) free of dimer impurity, 4, 4′-oxy-dibenzoic acid of Formula IV, ether impurity 3,5-di(propan-2-yl)-4-(propan-2-yloxy)benzoic acid of Formula V and the monoalkylated impurity 4-hydroxy-3-(propan-2-yl) benzoic acid of Formula VI; and decarboxylating 4-hydroxy-3,5-diisopropylbenzoic acid (Formula III) in presence of high boiling solvent and sodium hydroxide as a catalyst at high temperature to yield 2,6-diisopropyl phenol substantially free of ether impurity 1,3-di(propan-2-yl)-2-(propan-2-yloxy)benzene of Formula VII and monoalkylated phenol impurity 2-(propan-2-yl) phenol of Formula VIII. Propofol prepared by the process of the present invention is suitable for pharmaceutical use. | 2013-03-21 |
20130072574 | DIETARY SUPPLEMENTS CONTAINING EXTRACTS OF CINNAMON AND METHODS OF USING SAME TO PROMOTE ENHANCED SIRTUIN, CELL AND TELOMERE INTEGRITY - A dietary supplement composition is provided for enhancing the expression of a sirtuin gene or protein. An inventive supplement composition includes at least one cinnamon extract containing at least 0.5% doubly linked Type-A polymers by dry weight. The cinnamon extract is derived from the | 2013-03-21 |
20130072575 | Method and Composition for Treating Pain - Presented are methods of using topical analgesic compositions for rapid relief of muscular aches and pain where the analgesic composition has been stored at a temperature of less than 10° Centigrade prior to use. | 2013-03-21 |
20130072576 | Cationic Nanogels For Biotechnological Applications - The present invention relates to a biocompatible cationic nanogel comprising a polymer network, said polymer network comprising polymer units interconnected with one another through a cross-linking agent, wherein said polymer network can be obtained by polymerizing N-vinylcaprolactam and a cross-linking agent in a dispersed medium, in the presence of a cationic initiator and a cationic or non-ionic emulsifier. The invention also relates to methods for obtaining the mentioned nanogels as well as to pharmaceutical compositions comprising them. | 2013-03-21 |
20130072577 | Vaporized Medicants and Methods of Use - A method and formulation for delivering an active compound in a vaporized state using low temperatures to vaporize the formulation. The formulation contains an inert non-reactive compound that lowers the heat of vaporization of the formulation, and the active compound. The formulation may optionally contain glycerin, alcohol, and/or water. Examples of inert non-reactive compounds that can sufficiently lower the heat of vaporization of the formulation include propylene glycol and polysorbate. The formulation can be vaporized using a hand-held low temperature vaporizer or atomizer | 2013-03-21 |
20130072578 | ORODISPERSIBLE TABLETS OF ERYTHRITOL AND ISOMALT - Erythritol is granulated together with at least 10% w/w isomalt. Prior and/or after granulation a disintegrant is added and orodispersible tablets are prepared. The tablet has a disintegration time of less than 100 seconds, less than 90 seconds, preferably less than 80 seconds, more preferably less than 60 seconds and said disintegration time was determined according to the European Pharmacopoeia VI, Test method 2.9.1 by using a pharmaceutical disintegration tester model ZT 73 whereby 6 tablets having a surface of 1 square centimeter and a weight of 350 mg, at a compression force of 20 kN, were analyzed and mean values were calculated. The process for preparing the orodispersible tablet, its use, and the intermediate granulate are described as well. | 2013-03-21 |
20130072579 | METHOD OF PREPARAING ENTERIC HARD CAPSULE AND ENTERIC HARD CAPSULE PREPARED THEREBY - A method of preparing enteric hard capsules, and an enteric hard capsule prepared by the method. The method may include: dissolving an enteric base material, a capsule forming aid, and a neutralizing agent in water at room temperature to prepare an aqueous composition; heating the aqueous composition to a first temperature that is higher than a gelation start temperature of the aqueous composition; cooling the heated aqueous composition to a second temperature that is lower than the gelation start temperature; immersing a mold pin heated to a third temperature that is higher than the gelation start temperature into the aqueous composition; removing the mold pin from the aqueous composition to obtain a film coated on the mold pin; maintaining the film on the mold pin at a fourth temperature that is higher than the gelation start temperature for a first time period to fix the film onto the mold pin; and drying the fixed film at a fifth temperature for a second time period to obtain a capsule shell. | 2013-03-21 |
20130072581 | Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein SRM Assay - The current disclosure provides for specific peptides from the Secreted Protein Acidic and Rich in Cysteine (SPARC) protein and the derived ionization characteristics of those peptides that are advantageous for quantifying SPARC directly in formalin fixed biological samples by the method of Selected Reaction Monitoring (SRM) mass spectrometry. Such fixed biological samples include: formalin-fixed tissue/cells, formalin-fixed/paraffin embedded (FFPE) tissue/cells, FFPE tissue blocks and cells from those blocks, and formalin fixed and paraffin embedded tissue culture cells. SPARC protein is quantitated in biological samples by the method of SRM/MRM mass spectrometry by quantitating one or more of the peptides described herein. The peptides can be quantitated if they reside in a modified or an unmodified form. Examples of potentially modified forms of SPARC peptides include those bearing phosphorylation of a tyrosine, threonine, serine, and/or other amino acid residues within the peptide sequence. | 2013-03-21 |
20130072582 | METHODS FOR DIAGNOSING AND TREATING ENCEPHALITIS OR EPILEPSY - The invention provides methods of diagnosing or determining a cause of an autoimmune encephalitis or an epilepsy in a subject and of diagnosing a tumor in a subject, comprising the step of testing a biological sample of the subject for an antibody to LGI1. This invention further provides methods of treating an autoimmune encephalitis or an epilepsy, comprising the steps of detecting an antibody to LGI1 and treating a tumor associated with the disease. | 2013-03-21 |
20130072583 | METHOD OF PRODUCING A HYDROCARBON COMPOSITION - A method of producing a hydrocarbon composition, the method including providing a biomass raw-material; gasifying the raw-material in the presence of oxygen to produce a gas containing carbon monoxide, carbon dioxide, hydrogen and hydrocarbons possibly together with inert components; separately increasing the hydrogen-to-carbon monoxide ratio of the gas to a value of about 2; feeding the gas to a Fischer-Tropsch reactor; converting in the Fischer-Tropsch reactor at least a significant part of the carbon monoxide and hydrogen contained in the gas into a hydrocarbon composition containing C | 2013-03-21 |
20130072584 | METHOD OF FORMULATING LOW GRAVITY SPONGE RUBBER FOR AUTOMOTIVE WEATHERSTRIPS - The invention relates to automotive weatherstrip material. More specifically, the invention utilizes thermo-expandable microspheres in the sponge bulb member of the weatherstrip to produce a microcellular structure which provides a lower weight weatherstrip material with improved surface appearance and comparable stiffness to known materials for use in the automotive industry, and exhibiting a blown specific gravity of less than about 0.60 g/cc. | 2013-03-21 |
20130072585 | AQUEOUS COLD-CURE FLEXIBLE STABILIZER FORMULATIONS - Aqueous cold-cure flexible foam stabilizer including the following components:
| 2013-03-21 |
20130072586 | Stabilized Polyolefin Compositions - Disclosed are compositions comprising antioxidants and stabilizers, such as, acid scavengers or organic phosphorus stabilizers, and optionally further comprising co-stabilizers. The disclosed compositions are useful as stabilizers for polyolefins and other polymeric materials. The disclosed compositions and methods generally provide longer shelf lifes and better oxidative resistance to materials than currently available antioxidants. | 2013-03-21 |
20130072587 | SILICONE-CONTAINING POLYISOCYANURATE FOAM - Polyisocyanurate foams of closed cell structure and low density are obtained by reaction of an amino-functional hyperbranched organopolysiloxane polyol, polyisocyanate, trimerization catalyst, and blowing agent. | 2013-03-21 |
20130072588 | MEDIUM DENSITY FOAMS HAVING GOOD IMPACT RESISTANCE AND A PROCESS FOR THEIR PRODUCTION - Impact resistant, medium density molded polyurethane foams are produced by the process of the present invention. These foams include from 5 to 35% by weight of glass fibers having an average fiber length of from 12.5 to 50 mm and from 25 to 60% by weight of one or more particulate fillers having an average particle size of from 0.3 to 40 microns. | 2013-03-21 |
20130072589 | Phenolic foam - A phenolic foam is made by foaming and curing a foamable phenolic resin composition that comprises a phenolic resin, a blowing agent, an acid catalyst and an inorganic filler. The blowing agent comprises an aliphatic hydrocarbon containing from 1 to 8 carbon atoms and the inorganic filler is at least one selected from a metal hydroxide, a metal oxide, a metal carbonate and a metal powder. The phenolic foam has a pH of 5 or more. The phenolic foam has a higher pH value compared with conventional phenolic foam and reduces corrosion risk when in contact with metallic materials. The phenolic foam maintains excellent long-term stable thermal insulation performance, low water uptake and fire resistance performance and by using a hydrocarbon blowing agent, does not harm the environment as an ozone depleting or global warming material. | 2013-03-21 |
20130072590 | PHENOLIC FOAM - A phenolic foam is made by foaming and curing a foamable phenolic resin composition that comprises a phenolic resin, a blowing agent, an acid catalyst and an inorganic filler. The blowing agent comprises a blend of chlorinated aliphatic hydrocarbon containing 2 to 5 carbon atoms and an aliphatic hydrocarbon containing from 3 to 6 carbon atoms mixed in a ratio of 60/40 to 5/5 parts by weight. The inorganic filler is at least one selected from a metal hydroxide, a metal oxide, a metal carbonate and a metal powder. The phenolic foam has a pH of 5 or more and a water uptake less than 1 kg/m | 2013-03-21 |
20130072591 | USING THE LIGHT ADJUSTABLE LENS (LAL) TO INCREASE THE DEPTH OF FOCUS BY INDUCING TARGETED AMOUNTS OF ASPHERICITY - In general, the present invention relates to optical elements, which can be modified post-manufacture such that different versions of the element will have different optical properties. In particular, the present invention relates to lenses, such as intraocular lenses, which can be converted into aspheric lenses post-fabrication. Also, the present invention relates to a method for forming aspheric lenses post-fabrication. | 2013-03-21 |
20130072592 | METHOD OF PRODUCING CURED THIN FILM USING PHOTOCURABLE SILICONE RESIN COMPOSITION - A cured thin film may be easily prepared, by curing a photocurable silicone resin composition containing: (A) an organopolysiloxane having two or more alkenyl groups within each molecule, (B) an organohydrogenpolysiloxane having two or more hydrogen atoms bonded to silicon atoms within each molecule, and (C) a photoactive catalyst, by: (i) applying the composition to a substrate, (ii) obtaining a thin film in a semi-cured state by irradiating the applied coating with light, and (iii) heating the thin film in a semi-cured state to achieve complete curing, wherein the spectrum of the light irradiated in step (ii) has a maximum peak in a wavelength region from 300 nm to 400 nm, and the spectral irradiance of light of any wavelength within the wavelength region shorter than 300 nm is not more than 5% of the spectral irradiance of light of the maximum peak wavelength. | 2013-03-21 |
20130072593 | METHOD OF MANUFACTURING MONOLITHIC STATIONARY PHASE AND MONOLITHIC STATIONARY PHASE PRODUCED THEREBY - The present invention relates to a method of manufacturing a polymer-based monolithic stationary phase in an ionic liquid reaction medium via microwave-assisted vinylization and polymerization. The invention is time-effective and environmental friendly for not using volatile organic compounds. | 2013-03-21 |
20130072594 | LIQUID COAGULANT AND TIRE PUNCTURE SEALING MATERIAL SET - Disclosed is a liquid coagulant which can be injected into the inside of a tire without the need of removing the tire from a rim and which can prevent the scattering of a residue of a tire puncture sealing material when the tire is removed from the rim. The liquid coagulant can coagulate an emulsion that contains a natural rubber latex and/or a synthetic resin emulsion. The liquid coagulant contains a foaming agent capable of foaming the emulsion. | 2013-03-21 |
20130072595 | CURING OF EPOXY RESIN COMPOSITIONS COMPRISING CYCLIC CARBONATES USING MIXTURES OF AMINO HARDENERS AND CATALYSTS - A process for curing epoxy resins which comprises curing epoxy resin compositions comprising
| 2013-03-21 |
20130072596 | Thermally Robust Capsule System, And Composites Including The Capsules - A method of making capsules includes forming a mixture including a core liquid, a polyurethane precursor system, a first component of a two-component poly(urea-formaldehyde) precursor system, and a solvent. The method further includes emulsifying the mixture, adding a second component of the two-component poly(urea-formaldehyde) precursor system to the emulsified mixture, and maintaining the emulsified mixture at a temperature and for a time sufficient to form a plurality of capsules that encapsulate at least a portion of the core liquid. The capsules made by the method may include a polymerizer in the capsules, where the capsules have an inner capsule wall including a polyurethane, and an outer capsule wall including a poly(urea-formaldehyde). The capsules may include in the solid polymer matrix of a composite material. | 2013-03-21 |
20130072597 | STORAGE STABLE WATER BASED EPOXY-AMINE CURABLE SYSTEMS - The invention relates to non aqueous curing agents for water dispersed epoxy resins. The curing agent composition offers a binder pot life of several hours, and in the presence of a metal, such as zinc, nearly no hydrogen generation is observed. The present curing composition can be mixed with a metal powder to provide a storage stable paste. The curing agent composition and/or paste is fully compatible with an epoxy water based resin. After low shear blending, the epoxy curing agent and metal system is storage stable for several hours working pot life that provides for cured coatings having good performance. | 2013-03-21 |
20130072598 | Thermoplastics from Distillers Dried Grains and Feathers - A thermoplastic biobased material-containing composition comprising chemically-modified feathers and/or dried distillers grains and a process for forming the thermoplastic biobased material-containing composition. More specifically, the thermoplastic biobased material-containing composition comprises one or more of the following chemically-modified biobased materials: (a) acylated biobased material having a % Acyl Content that is at least 3% and a % Weight Gain that is at least 1%, and; (b) etherified biobased material having a % Weight Gain that is at least 2%; and (c) graft polymerized biobased material having a % Monomer Conversion that is at least 40%, a % Grafting Efficiency that is at least 30%, and a % Grafting that is at least 10%. | 2013-03-21 |
20130072599 | WOOD POWDER-CONTAINING MATERIAL, METHOD OF MANUFACTURING THE SAME, AND COMPACT - A wood powder-containing material includes wood powder having a volume average particle diameter of from about 1 μm to about 5 mm, an aliphatic polyester, and a condensed phosphate ester. | 2013-03-21 |
20130072600 | FIRE RETARDANT MOLDINGS AND METHOD FOR PRODUCING AND USING SUCH A MOLDING - A fire retardant molding contains a thermoplastic compound and an inorganic flameproof agent that is mixed with the thermoplastic compound and which acts by separating from water, having a proportion in the range of 10 wt % to 90 wt %. The fire retardant molding is produced by mixing the thermoplastic material with an inorganic flame-proofing agent, the flame-proofing agent having a proportion in the range of 20 wt % to 80 wt %, and by outputting the compound obtained by mixing, in particular as a flat product. The fire retardant molding is advantageously used, for example, in or on land-based vehicles, water-based vehicles, aircraft and buildings. | 2013-03-21 |
20130072601 | Sealing Composition - A sealant composition for the sealing of a punctured tyre including a liquid carrier, one or more viscosity and suspending agents, one or more fillers and sealants, and one or more polyacrylates. | 2013-03-21 |
20130072602 | PROCESS FOR THE PREPARATION OF POLYETHER CARBONATE POLYOLS - The present invention relates to a process for the preparation of polyether carbonate polyols by catalytic copolymerization of carbon dioxide (CO | 2013-03-21 |
20130072603 | COLOR CONTROL OF POLYESTER-COBALT COMPOUNDS AND POLYESTER-COBALT COMPOSITIONS - The present invention is to a composition made from a polyester produced by the acid or ester polyester process, a cobalt salt and a base, preferably an alkaline metal base. The composition can be made by blending a cobalt salt with a polyester which has been polymerized in the presence a alkaline metal ion derived from a basic alkaline metal compound, e.g. alkaline metal base or basic alkaline metal salt. The composition may optionally comprise an ionic compatibilizer, which may further be blended with a partially aromatic polyamide. This blend can be processed into a container having both active and passive oxygen barrier with an improved color and clarity than that achieved by cobalt alone. The use of the cobalt salt in combination with the base can also be used to improve the color of recycled polyester durin processing. | 2013-03-21 |
20130072604 | COMPOSITIONS CONTAINING BORANE OR CARBORANE CAGE COMPOUNDS AND RELATED APPLICATIONS - Compositions comprising a polymer-containing matrix and a filler comprising a cage compound selected from borane cage compounds, carborane cage compounds, metal complexes thereof, residues thereof, mixtures thereof, and/or agglomerations thereof, where the cage compound is not covalently bound to the matrix polymer. Methods of making and applications for using such compositions are also disclosed. | 2013-03-21 |
20130072605 | Elastomeric Composition for Pharmaceutical Articles - Elastomeric polymers and compounded elastomers have reduced amounts of leachables. The compound comprises a polymer and 50 to 100 phr of filler. The polymer is prepared by reacting a mixture of i) a C | 2013-03-21 |
20130072606 | MIXTURES OF SILVER AND ZINC OXIDE AS STABILIZER FOR FLAME-RETARDANT POLYAMIDES - Thermoplastic molding compositions comprising | 2013-03-21 |
20130072607 | NANOCLAY (NC) HYBRIDS AND ELASTOMER-NANOCLAY COMPOSITES PRODUCED THEREOF - A nanoclay (NC) hybrid is provided as well as a method of producing the NC hybrid. The NC hybrid comprises silanized montmorillonite and an amine and is produced by mixing a silanizing agent and montmorillonite in a non-flammable solvent at elevated temperature. Also provided is a modified NC hybrid in which the montmorillonite is ammonium- or aminium-substituted. | 2013-03-21 |
20130072608 | HEAT RESISTANT THERMOPLASTIC ARTICLES INCLUDING POLYHYDROXY POLYMERS - Disclosed is a molded or extruded thermoplastic article, including a thermoplastic polyamide composition including (a) a polyamide resin; (b) one or more polyhydroxy polymer(s); (c) one or more co-stabilizer(s); (d) one or more reinforcement agents; (e) and, optionally, a polymeric toughener. | 2013-03-21 |
20130072609 | SYTHESIS OF FUNCTIONAL FLUORINATED POLYHEDRAL OLIGOMERIC SILSESQUIOXANE (F-POSS) - A functional fluorinated polyhedral oligomeric silsesquioxane (“F-POSS”). The F-POSS, has a chemical structure: | 2013-03-21 |
20130072610 | NBR Composition and Sealing Rubber Material - Providing an NBR composition substantially free of containment of an insolubilized substance-generating causative substance so as to prevent generation of an insolubilized substance due to extraction by a fuel while which composition is excellent in ozone resistance, ejectability from kneader, and which composition realizes a first compression set and a second compression set which are both 46% or less. An NBR composition including a polymer obtained by mixing an acrylonitrile-butadiene rubber (NBR) with polyvinyl chloride (PVC), wherein the NBR composition is obtained without blending an insolubilized substance-generating causative substance, or, in case of blending, by blending an insolubilized substance-generating causative substance at an upper limit of 0.15 parts by weight or less, into 100 parts by weight of the polymer having a PVC content of 15.70 to 17.50 wt %. | 2013-03-21 |
20130072611 | PLASTICIZER AND METHOD OF PREPARING THE SAME - The present invention provides an ester plasticizer for polyvinyl chloride (PVC) resin, epoxy resin or urethane resin and a method of preparing the same. More particularly, the present invention provides an ester plasticizer using triacetin and coconut oil-based biodiesel as raw materials, which can prepare a resin composition having excellent plasticizing efficiency and improved physical properties such as tensile strength and the like. | 2013-03-21 |
20130072612 | INK FOR PRINTING ON MOLDED PARTS, AND METHOD FOR USING SAID INK - The present invention relates to a method for obtaining a molded object made of laminated thermoplastic resin, said object having a high-quality printed surface. The present invention also relates to the resulting molded objects and to an ink specially suited for use in the above-mentioned method. | 2013-03-21 |
20130072613 | Polymer compositions comprising semi-aromatic polyamides and graphene materials - A polymer composition having improved processing properties, in particular improved crystallization behavior, comprising a semi-aromatic polyamide and a graphene material. The graphene material may be a nano-graphene platelet. The semi-aromatic polyamide may comprise recurring units obtainable by a polycondensation reaction between at least one aromatic diamine and at least one non-aromatic diacid or derivatives thereof and/or recurring units obtainable by a polycondensation reaction between at least one aromatic diacid or derivatives thereof and at least one non-aromatic diamine. The composition may further comprise a polyamide different than the semi-aromatic polyamide. The composition may further comprise a filler. | 2013-03-21 |
20130072614 | INK COMPOSITION FOR CONTINUOUS INKJET PRINTING - An aqueous inkjet black ink composition for use in continuous ink jet printing is provided comprising black pigment particles dispersed with a polymeric dispersant or self dispersing pigment particles without the need for a dispersant; and at least one surfactant, wherein the at least one surfactant is selected to provide the ink composition with a 10-ms dynamic surface tension of less than 54 mN/m. The invention relates to continuous ink jet printing of an aqueous pigmented ink composition recycled from a main ink supply reservoir, employing a printer with a drop ejector and a drop deflector and a non-printing drop catcher capable of returning unprinted ink to the fluid delivery system following the capture of non-printing drops. The pigmented ink jet ink compositions provide for particularly suitable fluid properties on the drop catcher face that minimize printing defects that can occur during drop deflection during the printing of high dynamic range images at high speed. | 2013-03-21 |
20130072615 | POLYMERIZABLE COMPOSITION - A polymerizable composition includes: a polymerization initiator; a polymerizable compound; a tungsten compound; and an alkali-soluble binder. | 2013-03-21 |
20130072616 | HEAT/LIGHT-STABILIZED POLYAMIDE COMPOSITIONS - Heat and light-stabilized polyamide compositions containing a stabilization system that includes copper oxide and KBr, and have an excellent preservation of color and of the mechanical properties thereof after exposure to heat or to light; these compositions are especially useful for producing shaped articles in the automotive field. | 2013-03-21 |
20130072617 | TRANSPARENT HEAT RADIATING COATING COMPOSITION - The present invention provides a transparent heat radiating coating composition capable of forming a coating layer having excellent transparency and heat radiating properties. The transparent heat radiating coating composition of the present invention is a transparent heat radiating coating composition including a binder resin, a hydrotalcite-series compound and a resin dispersant with an amine value of 0 to 90 mgKOH/g, wherein the transparent heat radiating coating composition includes 50 to 290 parts by weight of the hydrotalcite-series compound based on 100 parts by weight of the binder resin. | 2013-03-21 |
20130072618 | METHOD FOR PRODUCING POLYMERIC BALLS OR BEADS CONTAINING METAL ELEMENTS - A method for producing polymeric balls or polymeric beads doped with at least one metal element is provided. The method may comprise the following steps: a) a step for forming polymeric balls or beads by polymerization, in an organic phase comprising a polymerization initiator, of at least one ethylenic monomer comprising at least one chelating ligand of at least one metal element; and b) a step for putting said polymeric balls or beads in contact with a solution comprising at least one metal element. | 2013-03-21 |
20130072619 | Heat-Curable Silicone Rubber Composition For Rubber Laminate - A heat-curable silicone rubber composition for a rubber laminate composed of a silicone-rubber layer and a rubber layer of a material other than silicone, the composition comprising: an alkenyl-containing diorganopolysiloxane (A) which comprises: 50 to 99 mass % of a diorganopolysiloxane (A1) that contains alkenyl groups, is capped at molecular terminals with alkenyl-containing organosilyl groups, and is free of alkenyl groups in side molecular chains; 1 to 50 mass % of an alkenyl-containing diorganopolysiloxane (A2) having two or more alkenyl groups in a side molecular chain; a fine silica powder (B); an organohydrogenpolysiloxane (C) having in one molecule at least two silicon-bonded hydrogen atoms; and an organic peroxide (D). | 2013-03-21 |
20130072620 | Low Gloss Aqueous Coating Compositions Containing Poly(Ethylene Oxide) - The present invention relates to aqueous coating compositions having low gloss for floor polishes, finishes and sealer, as well as wall and floor paints and sealers. These aqueous coating compositions contain one or more water soluble poly(ethylene oxide) resins having the general formula [—CH | 2013-03-21 |
20130072621 | PNEUMATIC OBJECT PROVIDED WITH A GASTIGHT LAYER CONTAINING A THERMOPLASTIC ELASTOMER AND A THERMOPLASTIC - A pneumatic object or inflatable article is provided with a gastight elastomer layer. The gastight elastomer layer includes a thermoplastic polyisobutylene block elastomer and hot-melt polymer microdomains based on at least one thermoplastic material. | 2013-03-21 |
20130072622 | POLYAMIDE RESIN COMPOSITION - A polyamide resin composition comprising a polyamide resin (A), glass (C), and optionally a styrene polymer (B | 2013-03-21 |
20130072623 | POLYOLEFIN ELASTOMER COMPOSITION FOR ARTIFICIAL LEATHER APPLICATIONS - The present invention relates to a thermoplastic polyolefin elastomer composition in powder form comprising (i) an olefin block copolymer or (ii) a substantially linear ethylene polymer and/or a linear ethylene polymer and propylene polymer blend. Said composition demonstrates good pulverizing and flow characteristics at ambient temperature. In another aspect, this invention relates to a process for preparing said thermoplastic polyolefin elastomer powder and applications for using said powder. In a further aspect, this invention relates to paper transfer molding said thermoplastic polyolefin elastomer composition into artificial leather, particularly for skins for automotive interior applications such as instrument panels. | 2013-03-21 |
20130072624 | MOLDED RESIN PRODUCT FOR VEHICLE STRUCTURAL MEMBER OR AIRCRAFT STRUCTURAL MEMBER - A molded resin product for a vehicle structural member or an aircraft structural member according to the present invention is formed by injection-molding of thermoplastic resin feedstock containing reinforcement fibers by using a screw provided at a leading end portion thereof with a mixer protruding in a radial direction. In the injection-molded product, the reinforcement fiber content ratio is greater than or equal to 20% by weight and the weight-average fiber length of the reinforcement fibers in an evaluation target area having a certain size is greater than or equal to 1 mm and less than or equal to 3 mm. | 2013-03-21 |
20130072625 | Method for the Preparation and Use of Bis (Alkoxysilylorgano)-Dicarboxylates - A method for preparing a bis(alkoxysilylorgano)dicarboxylate includes reacting a haloorganoalkoxysilane, a dimetal salt of a dicarboxyl functional compound, and a phase transfer catalyst. A quaternary iminium compound of a polyaza, polycycloalkene is useful as the phase transfer catalyst. The product may be a bis(alkoxysilylalkyl)fumarate, which is useful as a coupling agent in rubber compositions for tire applications. | 2013-03-21 |
20130072626 | Fiber-Reinforced, Thermoplastic Tape as a Strength Member for Wire and Cable - Fiber reinforced tape comprises a longitudinal axis, at least 30 percent by weight of a fiber and at least 2 percent by weight of a thermoplastic resin, with the proviso that at least 30 percent of the fibers in the tape are at least partially oriented along the longitudinal axis of the tape. The tape is useful as a strength member for wire and cable constructions, particularly fiber optic cable constructions. | 2013-03-21 |
20130072627 | JUST-IN-TIME COMPOUNDING IN AN INJECTION MOLDING MACHINE - A plastication unit for an injection molding machine, combining a heated plastication barrel with an entrance port and an exit port on opposing ends of the barrel; a hopper positioned to deliver ingredients to be compounded for injection molding to the entrance port of the barrel; and a helical plastication screw rotatably carried within the barrel and running the length of the barrel between the entrance and exit ports, which is operable to rotate and transmit the ingredients along the length of the barrel; wherein the plastication screw has at least one axial fluted extensional mixing element segment and the ingredients include at least one polymer for injection molding. Methods for injection molding with the plastication unit of the present invention and articles formed by the inventive methods are also disclosed. | 2013-03-21 |
20130072628 | COATING COMPOSITIONS CONTAINING CYCLOBUTANEDIOL - This invention is related to coating compositions comprising a polyester which further comprises 2,2,4,4-tetramethyl-1,3-cyclobutanediol residues, 1,4-cyclohexanedimethanol residues, and residues of a modifying glycol other than ethylene glycol, chosen from at least one of diethylene glycol, triethylene glycol, propylene glycol, neopentyl glycol, and 1,6-hexanediol; and 50 to 100 mole % of residues of at least one of phthalic anhydride, isophthalic acid, and terephthalic acid. | 2013-03-21 |
20130072629 | Low Halogen Content Disulfide Washed Polyarylene Sulfide - Methods for forming a low chlorine content washed polyarylene sulfide are described. Methods include washing a polyarylene sulfide that includes aryl halide endgroups with a solution that includes a disulfide compound. The solution can also include a catalyst and an organic solvent. During the disulfide wash, a nucleophilic substitution reaction occurs between the disulfide compound and aryl halides endgroups of the polyarylene sulfide. The nucleophilic substitution reaction is carried out at conditions to prevent chain scission of the polyarylene sulfide that includes the aryl halide endgroups. Compositions and products formed with the low chlorine content disulfide washed polyarylene sulfide are also described. | 2013-03-21 |
20130072630 | Low Chlorine Fiber Filled Melt Processed Polyarylene Sulfide Composition - Melt processed polyarylene sulfide compositions are described as are methods of forming the melt processed polyarylene sulfide compositions. The melt processed polyarylene sulfide compositions are formed according to a melt processing method that includes melt processing a mixture that includes a starting polyarylene sulfide, a disulfide compound and a filler. The melt processed polyarylene sulfide compositions may provide low chlorine content products having excellent strength characteristics. | 2013-03-21 |
20130072631 | METHOD FOR SEPARATING AN ORGANIC PHASE FROM AN ELECTROLYTE-CONTAINING AQUEOUS AND ORGANIC PHASE - A method for separating electrolyte-containing water from an organic phase by means of permeation on a hydrophobic separating means. The permeated organic solution is substantially depleted in water and the retained water is enriched with electrolytes. | 2013-03-21 |
20130072632 | POLYETHYLENE COMPOSITIONS AND CLOSURES FOR BOTTLES - A dual reactor solution process gives high density polyethylene compositions containing a first ethylene copolymer and a second ethylene copolymer and which have good processability, toughness, and environmental stress crack resistance combined with good organoleptic properties. The polyethylene compositions are suitable for compression molding or injection molding applications and are particularly useful in the manufacture of caps and closures for bottles. | 2013-03-21 |
20130072633 | Flexible Tubing Material and Method of Forming the Material - A flexible tubing material includes a radiation crosslinked blend of a first elastomeric polymer including a styrenic thermoplastic elastomer, an ethylene vinyl acetate elastomer, a polylefin elastomer with a second elastomeric polymer including a polyolefin elastomer, a diene elastomer, or combination thereof, with the proviso that the first elastomeric polymer and the second elastomeric polymer are different. In an embodiment, a method of making a material includes providing the first elastomeric polymer, providing the second elastomeric polymer, blending the first elastomeric polymer and the second elastomeric polymer, extruding or injection molding the blend, and crosslinking the blend with radiation. | 2013-03-21 |
20130072634 | Propylene Polymer Compositions - A propylene polymer composition comprising (percent by weight): | 2013-03-21 |
20130072635 | FLUOROPOLYMERS HAVING DIACRYLATE ENDS - Disclosed herein is a telechelic diacrylate fluoropolymer and a process for manufacture of the fluoropolymer. The diacrylate copolymer is of formula CH | 2013-03-21 |
20130072636 | CURABLE FLUOROELASTOMER COMPOSITION - Fluoroelastomer compositions comprising fluoroelastomers having copolymerized units of a nitrile-containing cure site monomer are cured with certain hydrazide curatives. The hydrazide is of the general formula R | 2013-03-21 |
20130072637 | CROSSLINKED FLUOROPOLYMER NETWORKS - Disclosed herein is a crosslinked fluoropolymer network formed by the free radical initiated crosslinking of a diacrylate fluoropolymer The diacrylate copolymer is of formula CH | 2013-03-21 |